In order to assess proliferation, CAR T cells were stimulated with LM7 tumor cells, and expression of the proliferative marker Ki-67 was assessed at day 3 and day 7 poststimulation (Supplemental Figure 6, G and H). This evidence concerns the gene MKI67 and neoplasm.